Authors:
Opened:Sep 2, 2021
Closes:Aug 1, 2023
Resolved:Aug 2, 2023
Spot Scoring Time:Sep 4, 2021
In what year will an HIV vaccine demonstrating at least 50% efficacy in Phase III clinical trials receive regulatory approval (e.g., from the FDA or EMA) for widespread use?
Mar 2032
(01 Aug 2029 - Apr 2036)
Mar 2032
(01 Aug 2029 - Apr 2036)
3 forecasters
Will a new tuberculosis vaccine be approved by the FDA, EMA, or PMDA before 2028?
80% chance
24
Will the World Health Organization prequalify moxidectin before 2027?
85% chance
34